Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v6-FR
Language French French
Date Updated 2020-04-01 2017-09-06
Drug Identification Number 02245922 02245922
Brand name SANDOZ DILTIAZEM T SANDOZ DILTIAZEM T
Common or Proper name DILTIAZEM DILTIAZEM
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 360MG 360MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-07-03 2017-07-03
Estimated end date Unknown 2017-11-27
Actual end date 2019-09-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments